Patients with end-stage cardiac disease can be managed with heterotopic heart<unk> , which is the most effective long term therapy, while implantable left ventricular assisted devices have also shown desirable outcomes. The short term mortality in these patients has been decreasing due to more refined surgical techniques, as well as the use of more advanced immunosuppressive regimen, but the morbidity in these patients has increased due to repeated transplant rejection episodes, and Cardiac allograft vasculopathy, which usually manifests as<unk>
Heart transplantation associated arrhythmias
Cardiac resynchronization therapy complications
Heart transplantation immunosuppressive therapy
Aortic dissection medical therapy
Stress cardiomyopathy surgery
ST elevation myocardial infarction complications
Cardiac resynchronization therapy contraindications
Atrial fibrillation cardiac surgery